/
/
/

Nephrocare Health Services Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
--32%32%
---15%
----
7%7%11%9%

Peer Comparison

Symbol
APOLLOHOSP
MANIPALHOS
MAXHEALTH
FORTIS
ASTERDM
MEDANTA
NH
KIMS
LALPATHLAB
AGARWALEYE
NEPHROPLUS
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
8,760₹124661 Cr59.6640.39207.67₹1942 Cr
727.25₹95990 Cr107.571.9611.95₹892 Cr
992₹95871 Cr65.83.3119.84₹1442 Cr
910₹68701 Cr65.563.5320.1₹1042 Cr
795.65₹68496 Cr214.940.316.76₹464 Cr
1,422.6₹39493 Cr71.015.9129.85₹556 Cr
1,911.8₹37993 Cr46.5510.1465.36₹806 Cr
765.7₹32095 Cr157.11.0412.74₹241 Cr
1,900₹31470 Cr58.0710.1142.51₹505 Cr
518.3₹16300 Cr109.861.4313.88₹133 Cr
713₹7012 Cr91.263.1916.66₹77 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Jun 2025Mar 2025Dec 2024
₹282 Cr₹266 Cr₹260 Cr₹228 Cr₹219 Cr₹197 Cr
₹7 Cr₹12 Cr₹3 Cr₹7 Cr₹4 Cr₹5 Cr
₹289 Cr₹277 Cr₹263 Cr₹234 Cr₹223 Cr₹203 Cr
₹242 Cr₹238 Cr₹221 Cr₹200 Cr₹187 Cr₹171 Cr
₹71 Cr₹65 Cr₹64 Cr₹54 Cr₹55 Cr₹49 Cr
₹2 Cr₹3 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr
₹45 Cr₹36 Cr₹36 Cr₹29 Cr₹30 Cr₹26 Cr
₹36 Cr₹33 Cr₹32 Cr₹24 Cr₹25 Cr₹20 Cr

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Less Impairment of Assets
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023
₹20 Cr₹5 Cr₹5 Cr₹5 Cr
₹18 Cr₹13 Cr₹6 Cr₹8 Cr
₹1078 Cr₹566 Cr₹402 Cr₹375 Cr
₹1078 Cr₹566 Cr₹402 Cr₹375 Cr
₹1116 Cr₹584 Cr₹414 Cr₹389 Cr
₹5 L₹96 Cr₹123 Cr₹81 Cr
-₹30 Cr-₹19 Cr-₹23 Cr-₹17 Cr
₹46 Cr₹26 Cr₹23 Cr₹17 Cr
₹6 Cr₹5 Cr₹3 Cr₹4 Cr
₹21 Cr₹108 Cr₹126 Cr₹86 Cr
₹143 Cr₹113 Cr₹71 Cr₹43 Cr
₹124 Cr₹63 Cr₹78 Cr₹38 Cr
₹13 Cr₹101 Cr₹93 Cr₹92 Cr
₹19 Cr₹7 Cr₹1 Cr₹1 Cr
₹299 Cr₹284 Cr₹243 Cr₹175 Cr
₹1437 Cr₹976 Cr₹782 Cr₹650 Cr
₹23 Cr₹226 Cr₹243 Cr₹196 Cr
₹841 Cr₹679 Cr₹564 Cr₹386 Cr
₹323 Cr₹282 Cr₹208 Cr₹146 Cr
₹1 Cr₹0₹0₹0
₹517 Cr₹396 Cr₹356 Cr₹239 Cr
₹6 Cr₹6 Cr₹69 L₹32 Cr
₹7 Cr₹0₹0₹0
₹7 Cr₹0₹0₹0
₹23 Cr₹10 Cr₹16 Cr₹10 Cr
₹46 Cr₹18 Cr₹20 Cr₹42 Cr
₹598 Cr₹431 Cr₹392 Cr₹325 Cr
₹171 Cr₹51 Cr₹0₹0
₹33 Cr₹27 Cr₹26 Cr₹26 Cr
₹317 Cr₹266 Cr₹203 Cr₹159 Cr
₹255 Cr₹155 Cr₹61 Cr₹14 Cr
₹8 Cr₹6 Cr₹7 Cr₹4 Cr
₹56 Cr₹40 Cr₹94 Cr₹121 Cr
₹839 Cr₹545 Cr₹390 Cr₹324 Cr
₹540 Cr₹261 Cr₹147 Cr₹150 Cr
₹1437 Cr₹976 Cr₹782 Cr₹650 Cr
₹109₹3,217₹2,310₹2,167
₹109₹643₹462₹433

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023
₹97 Cr₹87 Cr₹33 Cr-₹9 Cr
₹168 Cr₹93 Cr₹80 Cr₹69 Cr
-₹6 Cr-₹44 Cr-₹33 Cr-₹53 Cr
₹260 Cr₹136 Cr₹80 Cr₹7 Cr
₹233 Cr₹135 Cr₹72 Cr₹11 Cr
-₹410 Cr-₹125 Cr-₹51 Cr-₹78 Cr
₹157 Cr₹54 Cr₹27 Cr₹60 Cr
-₹21 Cr₹65 Cr₹48 Cr-₹7 Cr
₹126 Cr₹61 Cr₹14 Cr₹19 Cr
₹19 Cr₹2 L-₹1 Cr₹2 Cr
₹124 Cr₹126 Cr₹61 Cr₹14 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)704.90
Volume (₹)1.89 L
High (₹)715.70
Upper Circuit836.45
Low (₹)697.55
Lower Circuit557.65
Prev Close697.05
52W High (₹)769.75
Price713.00
52W Low (₹)446.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)7012.48 Cr
Div. Yield (%)0.00
PE Ratio91.26
Debt to Equity0.02
Price to Book4.62
Book Value109.48
EPS (TTM)7.64
Face Value2.00
ROE (%)9.22

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
APOLLOHOSPNSE
MANIPALHOSNSE
MAXHEALTHNSE
FORTISNSE
ASTERDMNSE
MEDANTANSE
NHNSE
KIMSNSE
LALPATHLABNSE
AGARWALEYENSE
NEPHROPLUSNSE
LTP
1W Low
1W High
Market cap (₹)
8760+41 (0.47%)
8641
8840.50
1,24,661Cr
727.25+17.35 (2.44%)
708.10
738
95,990Cr
992-2 (-0.20%)
974
1001.30
95,871Cr
910-5 (-0.55%)
892.80
920
68,701Cr
795.65+35.75 (4.70%)
754.05
798.80
68,496Cr
1422.6-22.3 (-1.54%)
1410
1491.80
39,493Cr
1911.8-10.9 (-0.57%)
1850.50
1929.40
37,993Cr
765.7+12.05 (1.60%)
755.20
778.55
32,095Cr
1900-16.1 (-0.84%)
1855.70
1934.90
31,470Cr
518.3+4.05 (0.79%)
505.90
528.80
16,300Cr
713+20.3 (2.93%)
686.10
720
7,012Cr

Nephrocare Health Services Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹71.34Cr; with other income of ₹7.46Cr, profit before interest and tax came to ₹46.8Cr. Interest expense was ₹2.21Cr; PBT before exceptional items stood at ₹44.6Cr. Basis: consolidated annual results.

Nephrocare Health Services Ltd Quaterly Results Key Takeaways

Nephrocare Health Services Ltd reported ₹281.75Cr total income from operations in Jun 2026, softer than ₹265.62Cr in Mar 2026 but higher than ₹219.19Cr in Mar 2025. Operating profit (before other income, interest and exceptional items) was ₹71.34Cr; with other income of ₹7.46Cr, profit before interest and tax came to ₹46.8Cr. Interest expense was ₹2.21Cr, taking profit before tax to ₹44.6Cr. After tax of ₹9.06Cr, profit after tax stood at ₹35.54Cr (vs ₹33.46Cr in Mar 2026 and ₹24.87Cr in Mar 2025).